Product Reports Resources Pricing Login Book a demo

Celator Pharmaceuticals

Biotech & Life Sciences · Dublin, Ireland · Founded 1999 · IPO 2013

Operator of a pharmaceutical company intended to improve clinical outcomes

Valuation $1.50B
Power Law Unicorn$1–10B valuation tier

Talent graph

Celator Pharmaceuticals's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

8 investors on Celator Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Business Development Bank of Canada
Series B+ 7 investors entered at this stage
ROTH Capital Partners
Ventures West
Valence Life Sciences
Domain Associates
TL Ventures
Thomas McNerney & Partners
BC Cancer Agency

Celator Pharmaceuticals mafia

Startups founded by Celator Pharmaceuticals alumni

Former Celator Pharmaceuticals employees who went on to start their own companies. Sorted by Dealroom signal score.

Upward HealthEst. 2017
EHEric HeilUnited States
Signal score91
NeurogastrxEst. 2012
Cyril De ColleUnited States
Signal score61
LucasPye BIOEst. 2018
TLTia L.United States
Signal score40
Larrk BioEst. 2018
FGFrederic GodderisUnited States
Signal score37

Book a demo to explore the full alumni network →

Global footprint

Where Celator Pharmaceuticals has talent and traffic

Workforce by country
🇮🇪 Ireland · Dublin HQ
Book a demo for the full country breakdown

Patent intelligence

$32M patent portfolio · 13 active families

Estimated portfolio value
$32M
2.1% of market cap · 4.4× smaller than top peer Exelixis ($140M)
13 active patent families
Where Celator Pharmaceuticals innovates Cancer researchCarcinosisDelivery vehicleDrugLiposome

Where Celator Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Celator Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Celator Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Celator Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Celator Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles